Superficial Bladder Cancer: Decreasing the Risk of Recurrence

ONCOLOGY

Volumn 10, Issue 11, 1996, Pages 1617-1628

  Grossman, H Barton ^a   Tex, W A ^a   Moncrief Jr , Deborah ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR; HUMAN; INCIDENCE; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 0030277564     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Lamm DL, Riggs DR, Trynelis CL, et al. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long term course of superficial transitional cell carcinoma of the bladder. J Urol 153:144-1450, 1995.
2. Weintjes MG, Badalament RA, Wang RC, et al: Penetration of mitomycin C in human bladder. Cancer Res 53(14):3314-3320, 1993.
3. Lamm DL, Crawford ED, Blumenstein B, et al: Maintenance BCG immunotherapy of superficial bladder cancer: A randomized prospective Southwest Oncology Group study. Proc Am Soc Clin Oncol 11:203, 1992.
4. Soloway MS, Masters S: Urothelial susceptability to tumor cell implantation: Influence of caterization Cancer 46:1158, 1980.